Immunotope Overview

  • Founded
  • 2002
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Immunotope General Information

Description

Developer of immunotherapy products created for the treatment and prevention of cancer and chronic viral infections. The company's immunotherapy platform provides the ideal combination of technologies for successful immunotherapy, use the exquisite sensitivity and specificity of the immune system for early detection of cancer, provide innovative tools and services for collaborative development of novel drug and diagnostic products, enabling patients with effective treatments that destroy tumors and prevent metastasis.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • The Pennsylvania Biotechnology Center
  • 3805 Old Easton Road
  • Doylestown, PA 18901
  • United States
+1 (251) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Immunotope Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Immunotope‘s full profile, request access.

Request a free trial

Immunotope Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of immunotherapy products created for the treatment and prevention of cancer and chronic viral infections. The
Drug Discovery
Doylestown, PA
000000&0

0000000

aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. E
0000 000000000
Kulmbach, Germany
00 As of 0000
000000000000

00000000

niam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute i
0000000000000
Waltham, MA
00 As of 0000
0000
0000 0000-00-00
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Immunotope Competitors (28)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Axolabs Private Equity-Backed Kulmbach, Germany 00 000000000000
000000000 00000000 Venture Capital-Backed Waltham, MA 00 0000 00000000000 0000
00000000 000000000 Venture Capital-Backed San Diego, CA 000 00000 000000&0 00000
00000000 Venture Capital-Backed San Carlos, CA 00 00000 00000000000 00000
0000000 Venture Capital-Backed Cambridge, MA 000 00000000000 000
You’re viewing 5 of 28 competitors. Get the full list »

Immunotope Patents

Immunotope Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170173135-A1 Cytotoxic t lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer Granted 13-Sep-2011 00000000000
US-10206990-B2 Cytotoxic t lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer Active 13-Sep-2011 00000000000
US-9624284-B2 Cytotoxic t lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer Active 13-Sep-2011 00000000000
US-20140220117-A1 Cytotoxic t lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer Granted 13-Sep-2011 00000000000 0
EP-2755679-A4 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer Granted 13-Sep-2011 A61K39/0011 0

Immunotope Executive Team (2)

Name Title Board Seat Contact Info
Ramila Philip Ph.D Co-Founder, President & Chief Scientific Officer
Mohan Philip Ph.D Chief Operating Officer & Co-Founder
To view Immunotope’s complete executive team members history, request access »